Market Overview

Five Prime Therapeutics Submits IND For FPA150, Expects To Initiate Phase 1 Trial In 1H18

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Biotech News FDA

 

Related Articles (FPRX)